These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

543 related items for PubMed ID: 19744259

  • 1. Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study.
    El-Sayed M, Anwar AE.
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):335-40. PubMed ID: 19744259
    [Abstract] [Full Text] [Related]

  • 2. A retrospective study of intravenous sodium stibogluconate alone and in combinations with allopurinol, rifampicin, and an immunomodulator in the treatment of Indian post-kala-azar dermal leishmaniasis.
    Ramesh V, Kumar J, Kumar D, Salotra P.
    Indian J Dermatol Venereol Leprol; 2010 Mar; 76(2):138-44. PubMed ID: 20228542
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparative efficacy of intralesional sodium stibogluconate (SSG) alone and its combination with intramuscular SSG to treat localized cutaneous leishmaniasis: Results of a pilot study.
    Negi AK, Sharma NL, Mahajan VK, Ranjan N, Kanga AK.
    Indian J Dermatol Venereol Leprol; 2007 Mar; 73(4):280. PubMed ID: 17682296
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of short-duration (twice weekly) intralesional sodium stibogluconate in treatment of cutaneous Leishmaniasis in India.
    Bumb RA, Mehta RD, Ghiya BC, Jakhar R, Prasad N, Soni P, Lezama-Davila C, Satoskar AR.
    Br J Dermatol; 2010 Oct; 163(4):854-8. PubMed ID: 20500797
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial.
    Reithinger R, Mohsen M, Wahid M, Bismullah M, Quinnell RJ, Davies CR, Kolaczinski J, David JR.
    Clin Infect Dis; 2005 Apr 15; 40(8):1148-55. PubMed ID: 15791515
    [Abstract] [Full Text] [Related]

  • 9. A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.
    Nilforoushzadeh MA, Jaffary F, Ansari N, Siadat AH, Nilforoushan Z, Firouz A.
    J Vector Borne Dis; 2008 Dec 15; 45(4):287-91. PubMed ID: 19248655
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical efficacy of intramuscular meglumine antimoniate alone and in combination with intralesional meglumine antimoniate in the treatment of old world cutaneous leishmaniasis.
    Munir A, Janjua SA, Hussain I.
    Acta Dermatovenerol Croat; 2008 Dec 15; 16(2):60-4. PubMed ID: 18541100
    [Abstract] [Full Text] [Related]

  • 12. Randomized, double-blind, controlled, comparative study on intralesional 10% and 15% hypertonic saline versus intralesional sodium stibogluconate in Leishmania donovani cutaneous leishmaniasis.
    Ranawaka RR, Weerakoon HS, de Silva SH.
    Int J Dermatol; 2015 Dec 15; 54(5):555-63. PubMed ID: 25600472
    [Abstract] [Full Text] [Related]

  • 13. Randomized, double-blind, comparative clinical trial on the efficacy and safety of intralesional sodium stibogluconate and intralesional 7% hypertonic sodium chloride against cutaneous leishmaniasis caused by L. donovani.
    Ranawaka RR, Weerakoon HS.
    J Dermatolog Treat; 2010 Sep 15; 21(5):286-93. PubMed ID: 20438389
    [Abstract] [Full Text] [Related]

  • 14. Liposomal amphotericin B in comparison to sodium stibogluconate for Leishmania braziliensis cutaneous leishmaniasis in travelers.
    Solomon M, Pavlotzky F, Barzilai A, Schwartz E.
    J Am Acad Dermatol; 2013 Feb 15; 68(2):284-9. PubMed ID: 22858005
    [Abstract] [Full Text] [Related]

  • 15. Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis.
    Asilian A, Sadeghinia A, Faghihi G, Momeni A.
    Int J Dermatol; 2004 Apr 15; 43(4):281-3. PubMed ID: 15090013
    [Abstract] [Full Text] [Related]

  • 16. The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis.
    Asilian A, Sadeghinia A, Faghihi G, Momeni A, Amini Harandi A.
    Ann Trop Med Parasitol; 2003 Jul 15; 97(5):493-8. PubMed ID: 12930612
    [Abstract] [Full Text] [Related]

  • 17. A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel.
    Wortmann G, Miller RS, Oster C, Jackson J, Aronson N.
    Clin Infect Dis; 2002 Aug 01; 35(3):261-7. PubMed ID: 12115091
    [Abstract] [Full Text] [Related]

  • 18. A comparative controlled trial of intralesionally-administered zinc sulphate, hypertonic sodium chloride and pentavalent antimony compound against acute cutaneous leishmaniasis.
    Sharquie KE, Najim RA, Farjou IB.
    Clin Exp Dermatol; 1997 Jul 01; 22(4):169-73. PubMed ID: 9499605
    [Abstract] [Full Text] [Related]

  • 19. Randomized, double-blind study on intralesional metronidazole versus intralesional sodium stibogluconate in Leishmania donovani cutaneous leishmaniasis.
    Somaratne VN, Ranawaka RR, Jayaruwan HM, Wipuladasa DM, de Silva SHP.
    J Dermatolog Treat; 2019 Feb 01; 30(1):87-91. PubMed ID: 29764246
    [Abstract] [Full Text] [Related]

  • 20. Synergistic Effect Of Oral Allopurinol And Intralesional Sodium Stibogluconate In The Treatment Of Cutaneous Leishmaniasis.
    Rashid HU, Ullah I, Adeeb H, Zeb M, Mohammad A, Rehman N.
    J Ayub Med Coll Abbottabad; 2020 Feb 01; 32(4):558-561. PubMed ID: 33225663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.